CF Management

Discover our Project

MyCyFAPP is a Project funded by the European Commission under the Framework Programme for Research and Innovation HORIZON 2020. A total of 12 Organisations from 7 European countries have joined backgrounds and expertise to successfully achieve a new Pancreatic Enzyme Replacement Therapy (PERT) plus make it accessible and user friendly to Cystic Fibrosis patients and families, and available as a mobile APP.

Objectives

to get to a scenario in which self-management of enzyme replacement in the European Cystic Fibrosis (CF) patients by means of a mobile application (APP) is progressively achieved and successfully implemented. 

What will the APP offer

Apart from a real-time optimal enzyme dosage prediction for a specific meal, the system will allow for a nutritional evaluation of the patients’ diet...

The reason for MyCyFAPP

The raison d'etre of this project is the need to develop/create an evidence-based tool to tackle the existing gap on the adapted-to-patients enzyme replacement dosage therapy.

A predictive model

We are going to develop and validate a model for optimal PERT adjustment, by integrating for the first time results obtained through in vitro and in vivo digestibility studies.

Results

MyCyFAPP will replace traditional in hospital out patients consultations (e.g. physicians and dieticians) by mobile consultations, allowing for a continuous follow-up and fast establishing of interventions if needed

EU Project number

 

ehealth

MyCyFAPP is a project funded by the European Commission under the Research and Innovation Framework Programme “Horizon 2020”